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Abstract
Background: Adherence is crucial for public health program effectiveness, though the benefits of increasing adherence
must ultimately be weighed against the associated costs. We sought to determine the relationship between investment in
community health worker (CHW) home visits and increased attendance at cervical cancer screening appointments in Cape
Town, South Africa.
Methodology/Principal Findings: We conducted an observational study of 5,258 CHW home visits made in 2003–4 as part
of a community-based screening program. We estimated the functional relationship between spending on these visits and
increased appointment attendance (adherence). Increased adherence was noted after each subsequent CHW visit. The costs
of making the CHW visits was based on resource use including both personnel time and vehicle-related expenses valued in
2004 Rand. The CHW program cost R194,018, with 1,576 additional appointments attended. Adherence increased from 74%
to 90%; 55% to 87%; 48% to 77%; and 56% to 80% for 6-, 12-, 24-, and 36-month appointments. Average per-woman costs
increased by R14–R47. The majority of this increase occurred with the first 2 CHW visits (90%, 83%, 74%, and 77%; additional
cost: R12–R26).
Conclusions/Significance: We found that study data can be used for program planning, identifying spending levels that
achieve adherence targets given budgetary constraints. The results, derived from a single disease program, are
retrospective, and should be prospectively replicated.
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Introduction
Health programs aimed at diseases such as HIV/AIDS,
tuberculosis, type 2 diabetes, hypertension, and cancer, require
individuals to return repeatedly to sites of clinical care in order to
be effective [1]. As such programs generally have upfront costs and
delayed benefits due to averted disease and death, interventions
are undertaken to increase participation, return, and adherence to
health recommendations [2]. Adherence interventions employ a
broad range of methods (e.g., telephone reminders, home visits,
and direct monetary incentives), rely on diverse theories, and
achieve variable success [3,4,5,6,7,8,9].
Increasing adherence requires potentially substantial monetary
expenditure beyond those needed to deliver the direct services of
the health program. Understanding the relationship between this
investment and the benefit of increased adherence is important
when planning health care programs. In the planning phase,
alternatives to population-based data must be sought to support
decision making and budgeting prior to implementation.
In South Africa, cervical cancer is the leading cause of cancer
and cancer mortality, a pattern still faced by developing countries
worldwide – cervical cancer being one of the two leading causes of
cancer death among women, with an estimated 270,000 deaths
annually [10]. Patterns of cervical cancer differ between developed
and developing countries, with the majority of cervical cancer
burden occurring in developing countries, typically detected via
symptoms at later invasive stages [11]. High-quality screening
programs relying on repeated, periodic cervical Pap smears have
led to population benefit in developed countries [12]. In most
developing countries, the lack of organized cervical cancer
screening means that reductions in cervical cancer mortality have
yet to be achieved. While South Africa has instituted a screening
policy in the public sector with the goal of providing screening at
age 30, 40, and 50 to 70% of women, current coverage and follow-
up do not meet these goals [13,14]. In addition to Pap smears, the
effectiveness of a variety of other screening technologies, with
fewer clinic visits between screening and treatment, has been
studied [15,16] as have two human papillomavirus (HPV) vaccines
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that prevent infection with viral subtypes responsible for the
majority of cervical cancers [17,18]. Because both vaccines are
prophylactic, they are ideally used prior to sexual debut. As such,
even with a choice to vaccinate teenage girls now which would
require overcoming barriers like affordability, delivery mecha-
nisms for adolescents, and uncertainty about the long-term
benefits, policymakers must still make important decisions
regarding screening to provide direct benefits to women currently
in their 30s and 40s.
To support decision making relating to cervical cancer
screening in South Africa, this analysis focuses on the relationship
of monetary expenditure and a key element of prevention
effectiveness – adherence – in the context of a large community-
based screening program in resource poor, peri-urban areas near
Cape Town. Our analysis extends previously published work [19]
that quantified the resources used to conduct unlimited commu-
nity health worker (CHW) home visits and associated levels of
screening appointment attendance. For our present analysis, we
increased both the quantity and range of the data previously
examined, widening the window of appointments covered from 1
to 2 years and extending longitudinal follow-up from 2 to 3 years.
Motivated to generate useful information for program planning
and cost-effectiveness analyses, we illustrate a method for
estimating how choosing intermediate levels of CHW program
intensity, expressed in monetary terms, translates into expected
changes in appointment attendance.
Methods
Study setting and population
The screening program and community health worker (CHW)
home visit program we analyze here have been described
previously [19,20]. Briefly, in the context of the program, a study
was conducted to evaluate cervical cancer screening alternatives at
multiple clinic sites in a largely poor, black peri-urban area in
which 60% of households are part of informal settlements without
full electric, sewage, and road services. Women age 35–65 years
were recruited from the community via posters placed in
community health centers and a variety of community-based
outreach programs that included presentations at churches,
community meetings, and radio programs. Cervical cancer
screening was performed at 3 sites on the grounds of existing
health facilities. The screening study enrolled 7,000 eligible
women, approximately 10–15% of the 50,000–70,000 women
age 35–65 living in Khayelitsha [21,22].
The screening study was approved by the institutional review
boards of Columbia University (New York, NY) and the
University of Cape Town (Cape Town, South Africa). All
participants provided written informed consent. The study was
conducted according to the principles expressed in the Declaration
of Helsinki.
Women in the screening study have a series of scheduled follow-
up appointments (1-month, 6-month, 12-month, 24-month, and
36-month) in which they receive cervical cancer screening tests.
Women testing positive receive diagnostic colposcopy and biopsy
as well as treatment and referral based on the results of these
diagnostic tests. For women who do not return spontaneously for
their scheduled appointments, groups of CHWs drive through the
community making home visits to reschedule appointments and
encourage attendance, with CHW visits repeated until return is
achieved or further participation is declined. Women participating
in the screening study with 6-, 12-, 24-, or 36-month appointments
scheduled in 2003–4 were considered eligible for inclusion in this
analysis.
Cost data
We estimated the cost of the entire CHW home visit program
which made visits both to women enrolled in the study and to
other women receiving services from the larger screening program.
We adopted an ingredients-based approach to costing. We
identified the types of resources used: 1) CHW time spent driving
and making home visits, 2) fuel used during CHW visits, 3)
maintenance and depreciation of the vehicles. For each resource
type, we then assigned a monetary value for a unit quantity.
Finally, the number of units used and unit values were multiplied
and then summed to produce a total cost estimate. All costs are
presented in 2004 Rand (R) with prices from other years adjusted
to 2004 levels based on the South African Gross Domestic Product
deflator [23].
In the program, CHW home visits were grouped into trips, with
a trip being defined as leaving the clinic, driving a circuit through
the community making multiple home visits, and returning to the
clinic. The total amount of CHW time per home visit equaled the
number of CHWs on the trip multiplied by the duration of the trip
divided by the number of home visits. CHW time was valued at
R2,500 per month for a 1,840 hour work year (R16.3 per hour).
Fuel and vehicle maintenance costs were derived directly from the
project’s cost accounting system. Vehicle depreciation was based
on purchase price, excluding taxes and duties, and used a five-year
straight-line formula assuming a 3% discount rate and no resale
value [19]. As program vehicles are used for other purposes, we
estimated that 50% of usage was attributable to CHW home visits.
All fuel, maintenance and vehicle depreciation costs were,
therefore, multiplied by 50%. The total CHW home visit cost
was divided by the number of CHW home visits conducted to
produce a cost per home visit which could then be applied to those
CHW visits associated with women enrolled in the screening study
in subsequent analyses.
Appointment data
Attendance for scheduled appointments was classified into three
categories: 1) spontaneous, on-time return; 2) late return with
CHW visit(s); 3) no return despite CHW visits. Two sources of
data were used to classify appointment attendance. First, the study
appointments database indicated the date when individuals
attended appointments compared to their scheduled dates.
Second, weekly CHW summary logbooks were transcribed and
verified against individual CHW visit reports to create an
electronic database of CHW home visits. By linking the databases,
we identified on-time versus late attendance and how many CHW
visits preceded appointment attendance.
CHW spending limits and attendance
In the study, CHW home visits continued until a woman
returned or declined further participation. In addition to analyzing
the cost of CHW visits relative to return rates as observed, we
considered hypothetical alternative policies for CHW visits.
Specifically, we asked how much would be spent and what level
of appointment attendance achieved if each woman could receive
no more than a fixed number of CHW visits for a given
appointment type. For this analysis, we assumed that CHW visits
caused additional appointment attendance and that those women
who did not return after receiving the maximum number of CHW
visits allowed under a given policy would not return spontaneously
afterwards.
Under these assumptions, we constructed response functions
relating spending (the independent variable) to appointment
attendance (the dependent variable) via CHW visits. For each
appointment type, we sequentially imposed hypothetical policies
Spending to Increase Adherence
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where the maximum number of CHW visits was set at higher and
higher levels. For each policy, we used the observed data to
estimate the additional percentage of all women eligible for that
appointment type who returned with no more than the maximum
number of CHW visits allowed by the policy. Based on the
number of additional CHW visits performed under the policy, we
also calculated the additional cost. Taken together, these quantities
formed the response functions for each appointment type. Each
function’s input was spending per woman on CHW visits with the
output being the percentage of women who returned for their
appointments.
Statistical analyses
Intercooled Stata 8.2 (Stata Corporation, College Station,
Texas, USA) was used for all statistical analyses. Linking and
classification of study databases and CHW logbook databases were
performed using Excel 2003’s Visual Basic for Applications
(Microsoft Corporation, Redmond, Washington, USA).
Results
In 2003–4, 981 CHW trips were conducted. The mean number
of women visited per trip was 5.4 (standard deviation: 2.3, range:
1–18), and the mean number of CHWs who went on each visit was
2.9 (standard deviation: 0.7; range: 2–5). The mean time spent
visiting each woman during a trip was 21.9 minutes (standard
deviation 13.6; range: 3–150). This implies that the 5,258 CHW
visits conducted required 5,566 hours of CHW time driving
throughout the community and visiting women in their homes.
Over the 2 year period, the value of CHW time spent making
home visits was R91,399, while fuel, vehicle maintenance, and
depreciation costs attributable to CHW visits were R37,704,
R28,130, and R36,785, respectively. In total, the CHW home
visits cost R194,018 with a cost per CHW home visit of R36.6.
Of the 5,258 CHW visits conducted, 4,617 visits were made for
women enrolled in the study, identified via the study database
linkage, with the remainder targeting women receiving screening
services through the program but not enrolled in this study.
Subsequent results are reported solely for enrolled women.
Table 1 shows that 74%, 55%, 48%, and 56% of women
attended their scheduled 6, 12, 24, and 36 month appointments
spontaneously and without CHW visits.
Figure 1, Panel A shows the percentages of women who
required 1 or more CHW visits for each appointment type. In
general, the percentage of women who did not return for their
scheduled appointments spontaneously increased for subsequent
appointment types. While the 36 month appointment had a
somewhat lower percentage of women requiring CHW visits than
for the 12 and 24 month appointments, the 12, 24, and 36 month
appointment types all had significantly higher percentage of
woman requiring CHW visits than did the 6 month appointment.
Figure 1, Panel B shows the percentage of women requiring 1 or
more CHW visits who never returned despite those CHW visits.
Failure to return despite CHW visits is greater in the 24 and 36
month appointments than in the 12 and 6 month points.
The number of CHW visits required for each appointment type
was: 338, 1,680, 1,928, and 671 for the 6, 12, 24, and 36 month
appointments, respectively (Table 1). The total additional cost per
woman ultimately attending these appointment types increased for
subsequent appointments and was: R13.6, R35.4, R46.6, and
R38.0, respectively.
Figure 2 and Table 1 show the relationship between increasing
the number of women attending appointments after CHW home
visit(s) and the increased cost associated with those home visits by
appointment type. Attendance without CHW visits is nearly 75%
for the 6-month appointment type but is between 48% and 56%
for the 12-, 24-, and 36-month appointments. After 2 CHW visits,
6-month attendance increased to 90% of appointments at a cost of
R12.3. After 2 CHW visits, 12-, 24-, and 36-month attendance
increased to 83%, 74%, and 77% at costs of R18.1, R26.4, and
R21.0 respectively. For these latter appointment types, using a
policy of no more than 2 CHW home visits per woman per
appointment type resulted in at least 95% of women who ever
returned attending their appointments at less than 60% of the cost
of making CHW visits until a woman returned or declined further
participation. For the 6-month appointment, similar results were
achieved if the policy was having no more than 1 CHW home visit
per woman per appointment.
Table 1. Relationship of attendance and CHW visits*,**.
6 month (n =1,003) 12 month (n =1,992) 24 month (n=1,928) 36 month (n =647)
Visit Policy*** # Attending CHW Visits # Attending CHW Visits # Attending CHW Visits # Attending CHW Visits
0 740 0 1,098 0 944 0 453 0
1 892 201 1,559 533 1,322 532 575 182
2 906 305 1,650 817 1,448 1,044 624 356
3 907 326 1,702 1,153 1,490 1,440 640 515
4 907 338 1,720 1,333 1,508 1,684 645 595
5 – – 1,729 1,523 1,513 1,809 646 635
6 – – 1,735 1,613 1,517 1,899 646 647
7 – – 1,739 1,655 1,517 1,920 646 647
8 – – 1,739 1,671 1,518 1,928 647 671
9 – – 1,739 1,680 – – – –
*CHW – community health worker.
**The counts of the number of women attending appointments and the number of CHW visits made are both cumulative.
***Visit policy defined as no more than ‘x’ CHW visits per woman per appointment type.
doi:10.1371/journal.pone.0005691.t001
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Discussion
In the context of this South African cervical cancer screening
program, high levels of repeated attendance (.75%) were
achieved at scheduled screening appointments using community
health worker (CHW) home visits. For follow-up appointments
scheduled 1 to 3 years after initial screening, CHW home visits
represented an appreciable additional cost (above R35 per woman
screened). As cervical cancer prevention programs that achieve
high adherence can be both effective and cost-effective [24,25]
and thereby justify public health spending, we examined potential
efficiencies within CHW efforts to maintain adherence. By
evaluating the patterns of CHW visits and women’s subsequent
attendance at their screening appointments, we found the vast
majority of additional attendance (.95%) occurred with no more
than 2 CHW visits per woman per appointment type, requiring
approximately 60% or less of the cost of the unlimited CHW visit
program.
An important limitation is the generalizability from this study to
current South African cervical cancer screening policy. While our
study evaluates participant adherence over a 3 year follow-up
period, current South African recommendations involve screening
at 10 year intervals (at age 30, 40, and 50 years). In our study,
adherence without intervention declined as the interval between
Figure 1. CHW visits and patient failure to return. Shown in the graph are the percentage and 95% confidence intervals of women who
received 1 or more CHW visits by appointment type during 2003–4 (Panel A, blue squares); and the percentage and 95% confidence intervals of
women receiving CHW visits who did not attend their scheduled appointments despite those visits (Panel B, red squares).
doi:10.1371/journal.pone.0005691.g001
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screening appointments lengthened, and it is quite possible that
the level of adherence after 10 years would be very low. Such low
adherence would certainly require some intervention. However, it
could be that the effectiveness of a CHW-based adherence
program after 10 years would be low or simply be more costly
given the large portion of screened individuals that might require
CHW visits. Interestingly, Goldie et al. find that using screening
intervals of 5 years (age 35, 40, and 45 years) appears more
effective and cost-effective than screening every 10 years (age 30,
40, and 50 years) in South Africa [26]. Combining this finding
with the possibility of lower adherence over longer screening
intervals, 5 year screening intervals may be even more attractive.
While the costs and adherence observed in the context of the
study accurately reflect the experience in one peri-urban center
in South Africa, other locations and interventions may result in
different costs and impact of CHW visits on adherence. For
example, in a pre-post community-based study, the use of
intensive pre-counseling by CHWs was associated with an
increase of more than 50% in the proportion of women
choosing voluntary counseling and testing for HIV, compared
to shorter, standard nurse-provided counseling. Similarly, it was
associated with increases in self-reported consistent condom use
over 1 and 6 month periods (increased 10% and 5% respectively)
(Lynette Denny, University of Cape Town, unpublished data,
2009). In another local program providing CHW home visits
and basic nursing care for people living with HIV/AIDS,
orphans, and the elderly [27], the use of bicycles by 175 CHWs
was expected to increase their average number of home visits
conducted from 6–8 to 12–16 per day with the bicycles costing
approximately $300/bicycle (2008 USD) and projected to have
useful lives of 5–10 years (Amanda Zar, MaAfrika Tikkun,
personal communication, 2009). In such programs, the costs and
effectiveness associated with the choice to implement a CHW
program and the intensity with which to equip and utilize the
program could be evaluated using the method described in this
study. As the use of CHWs has expanded at a national level in
South Africa [28], such future studies could be used to assess the
generalizability of our findings.
We note that alternatives to CHW home visits such as cell
phone-based interventions were not tested in the study, though, in
theory, they could be more effective and/or less costly than CHW
visits. While phone ownership was quite low in our sample of 35–
65 year old women, cell phone subscriptions have nearly tripled in
South Africa since 2003, making the use of cell phones an
important feature for a variety of services offered to relatively
resource poor individuals in South Africa and elsewhere [23,29].
In some contexts, the ease with which cell phone plans are
switched and phone numbers changed as well as the frequency of
cell phone thefts leave open the question of the most effective
means of maintaining long-term contact to deliver healthcare
services.
It is important to emphasize that the response functions relating
costs due to CHW visits and appointment attendance are based on
hypothetical policies of making no more than a given number of
CHW visits for a given woman and appointment type. Such
policies were not prospectively tested in the screening population
to produce observed counterfactuals. However, the patterns of
return for appointments across appointment types are plausible –
earlier appointments with shorter time periods between clinical
contacts (6-month and 12-month appointments) have greater
spontaneous attendance and/or greater responsiveness to the first
CHW home visit compared to 24- and 36-month appointments
(Figure 2). Additionally, appointment attendance levels after CHW
home visits are also broadly similar for the 24- and 36-month
appointment types, suggesting the emergence of more stable
longer term usage patterns.
Adherence response functions can be used in a variety of ways.
First policymakers can calculate how, under a fixed budget,
different intervals between clinical contacts may lead to different
rates of appointment attendance. Alternatively, for a target level of
appointment attendance, the associated cost can be computed. For
model-based cost-effectiveness analyses, levels of adherence are
entered as a parameter based on initial assumptions. The impact
of the adherence parameter on model-simulated outcomes is
typically explored via sensitivity analyses in which the level of
adherence is varied systematically. However, as we demonstrate,
Figure 2. Relationship between increased attendance and additional cost. Shown in the graph are the response functions relating the
additional cost of policies allowing greater number of CHW home visits per woman to increases in appointment attendance. Separate functions are
shown for 6-month appointments (green circles), 12-month appointments (blue triangles), 24-month appointments (yellow squares), and 36-month
appointments (orange diamonds).
doi:10.1371/journal.pone.0005691.g002
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different levels of adherence can be achieved through different,
non-linear levels of program expenditure, and thus sensitivity
analyses of adherence could be improved by simultaneously
varying the level of adherence and its associated costs based on
response functions like those we have estimated here.
Substantial improvements in appointment attendance can be
achieved in a South African cervical cancer screening context
using community health worker home visits. As home visits require
money and resources that could be used to provide other
healthcare services, seeking to maximize attendance while
controlling expenditure is both important and prudent. In this
context, we illustrate a method for estimating the relationship
between monetary investment in subprograms focusing on
adherence and observed increases in adherence, using data from
a longitudinal, community-based demonstration project. Such an
approach may be useful for public health program planning and
budgeting across a broad range of diseases and country settings.
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